Ironwood pharmaceuticals revenue
WebFeb 17, 2024 · Michael Dabaie Ironwood Pharmaceuticals Inc. reported fourth quarter revenue and adjusted earnings above analyst expectations. Fourth quarter total revenue came to $116.7 million, down from... WebIronwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results February 13, 2024 Ironwood Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of …
Ironwood pharmaceuticals revenue
Did you know?
WebSep 27, 2024 · P/E (5.61), EV/EBITDA (9.28), and Price/Sales (5.37) are 30-80% lower than the sector medians. Balance sheet of IRWD has been steadily improving over the past several years. Revenue has grown... WebIronwood Pharma Ironwood Revenue $422.4 M Employees 219 Primary Industries Pharmaceuticals Manufacturing Funding History Ironwood Pharmaceuticals raised a total of $1.4 B in funding over 11 rounds, and is a public traded company. CEO Thomas McCourt Stock Symbol NASDAQ: IRWD Ironwood Pharmaceuticals Executive Team & Key Decision …
WebGet the detailed quarterly/annual income statement for Ironwood Pharmaceuticals, Inc. (IRWD). Find out the revenue, expenses and profit or loss over the last fiscal year. WebApr 6, 2024 · Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company, which is advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is develops and commercializes GI product opportunities in areas of significant unmet need, leveraging its demonstrated expertise and capabilities in GI diseases.
WebMar 24, 2024 · Ironwood Pharmaceuticals has 5 employees across 2 locations and $410.6 m in annual revenue in FY 2024. See insights on Ironwood Pharmaceuticals including … WebFeb 16, 2024 · BOSTON, February 16, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its fourth quarter and full year 2024 results and recent business performance.
WebApr 15, 2024 · Analysts have estimated the company’s revenue for the quarter at $100.05 million, with a low estimate of $99.3 million and a high estimate of $101 million. According to the average forecast, sales growth in current quarter could jump up 2.60%, compared to the corresponding quarter of last year.
WebIronwood Pharmaceuticals. 100 Summer Street. Suite 2300. Boston MA 02110. Entrance at the corner of Devonshire St. and Summer St. [email protected]. Tel – … dunk low carolina blueWebIronwood Pharmaceuticals, headquartered in Boston, Massachusetts, and established in 1998, is a specialty and generic drug manufacturing company specializing in … dunk low born x raisedWebNov 3, 2024 · Collaboration Revenue to Ironwood: Ironwood recorded $105.2 million in collaboration revenue in the third quarter of 2024 related to sales of LINZESS in the U.S., a 5% increase compared to $100.4 million for the third quarter of 2024. See U.S. LINZESS Commercial Collaboration table at the end of the press release. dunk low celestiWebNov 6, 2024 · Ironwood (IRWD) delivered earnings and revenue surprises of 64.29% and 10.71%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? dunk low chicago 75WebIronwood Pharmaceuticals Questions What is the annual revenue of Ironwood Pharmaceuticals? Is Ironwood Pharmaceuticals growing? Who is the COO of Ironwood Pharmaceuticals? How many people are employed at Ironwood Pharmaceuticals? Where is Ironwood Pharmaceuticals based? What is the NAICS code for Ironwood Pharmaceuticals? dunk low champion redWebIronwood Pharmaceuticals. Jun 2024 - Present11 months. Boston, Massachusetts, United States. Strategic finance professional at Ironwood Pharmaceuticals, a $500M revenue commercial pharmaceuticals ... dunk low chicago bullsWebAccording to Ironwood Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $0.42 B . In 2024 the company made a revenue of $0.41 B an increase … dunk low christmas